129 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Recruiting Serum Autotaxin Levels in Cholestasis of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
22 Recruiting Interrogating Potential Therapeutic Targets for Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Intervention: Other: No intervention
23 Recruiting Compassionate Use of Omegaven IV Fat Emulsion
Conditions: Cholestasis;   Liver Disease
Intervention: Drug: Omegaven IV
24 Not yet recruiting Comparison of Diagnostic Accuranccy Before or After Stricture Dilation in Biliary Stricture
Condition: Biliary Strictures
Intervention: Procedure: Multimodal tissue-sampling methods before and after stricture dilation
25 Not yet recruiting A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease
Intervention: Drug: Vancomycin
26 Recruiting Disease Status in Primary Sclerosing Cholangitis by Elastography
Conditions: Primary Sclerosing Cholangitis;   Elastography;   Hepatic Fibrosis;   Magnetic Resonance Imaging
Intervention: Device: MR Elastography (MRE) and FibroScan
27 Not yet recruiting Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.
Condition: Sclerosing Cholangitis
Intervention: Biological: Fecal Microbiota Transplantation
28 Not yet recruiting Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
Conditions: Cholestasis;   Liver Disease
Interventions: Drug: Enteral fish oil;   Drug: Ursodeoxycholic Acid;   Drug: Placebo
29 Available SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury
Conditions: Cholestasis;   Growth Failure
Intervention: Drug: SMOFlipid
30 Recruiting B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
31 Recruiting IBAT Inhibitor A4250 for Cholestatic Pruritus
Condition: Biliary Cirrhosis, Primary
Intervention: Drug: A4250
32 Not yet recruiting Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Condition: Cholestasis
Intervention: Drug: Intralipid 20% I.V. Fat Emulsion
33 Recruiting Radiological Investigation of Bile Duct Obstruction
Condition: Gallstone Disease
Interventions: Procedure: Cholecystectomy and intraoperative cholangiography;   Procedure: Magnet resonance cholangio-pancreaticography;   Device: magnet resonance imaging;   Device: catheter
34 Recruiting Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Conditions: Liver Cancer;   Anxiety Disorder;   Depression;   Small Cell Lung Cancer;   Extrahepatic Bile Duct Cancer;   Malignant Mesothelioma;   Pancreatic Cancer;   Esophageal Cancer;   Gastric Cancer;   Non-small Cell Lung Cancer
Intervention: Other: Early palliative care
35 Recruiting Omegaven® as Parenteral Nutrition
Condition: Cholestasis
Intervention: Drug: Omegaven
36 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
37 Recruiting Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
Conditions: Breast Cancer;   Colon Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastrointestinal Cancer;   Liver and Intrahepatic Biliary Tract Cancer;   Lung Cancer;   Metastatic Cancer;   Pancreatic Cancer;   Rectal Cancer;   Thyroid Gland Medullary Carcinoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Drug: Cu 64 anti-CEA monoclonal antibody M5A IV
38 Recruiting Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Conditions: Pancreatic Neoplasms;   Cholestasis
Interventions: Drug: nab-paclitaxel;   Drug: Gemcitabine
39 Recruiting Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis
40 Recruiting Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis
Conditions: Primary Sclerosing Cholangitis;   Inflammatory Bowel Disease

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years